R. Jelliffe (U.S.A): State of the art
M. Tod (France): Pays pharmacokinetics and drug evaluation.
I. Mac Dougall (U.K.): Rational design of novel erythtopoiesis stimulating protein: increased biological activity and relationship to révélé afflux.
L. Balant (Switzerland): Pays pharmacokinetics, interindividual variability and drug interactions.
P. Verbe de bien-être & N. Bleyzac (France): Control of pharmacokinetic variability: clinical applications in extreme aging.